Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H10O2 |
Molecular Weight | 102.1317 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(O)=O
InChI
InChIKey=NQPDZGIKBAWPEJ-UHFFFAOYSA-N
InChI=1S/C5H10O2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H,6,7)
Molecular Formula | C5H10O2 |
Molecular Weight | 102.1317 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide]. | 1976 |
|
[Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)]. | 1976 |
|
Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. | 1999 May 14 |
|
Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. | 1999 Sep |
|
Microflora-associated characteristics in faeces from allergic and nonallergic infants. | 2000 Nov |
|
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. | 2001 |
|
Evidence for an essential arginine in the flavoprotein nitroalkane oxidase. | 2001 |
|
The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women. | 2001 Aug |
|
Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation. | 2001 Aug 22 |
|
Effect of the liquid upflow velocity on thermophilic sulphate reduction in acidifying granular sludge reactors. | 2001 Feb |
|
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. | 2001 Feb |
|
Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers. | 2001 Jan |
|
Short- and long-term effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women. | 2001 Jul |
|
Influence of supplemental chromium on concentrations of liver triglyceride, blood metabolites and rumen VFA profile in steers fed a moderately high fat diet. | 2001 Jul |
|
Characterization of partially transesterified poly(beta-hydroxyalkanoate)s by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2001 Jul-Aug |
|
Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability. | 2001 Jul-Aug |
|
Significance of substrate hydrophobicity for recognition by an oligopeptide transporter (PEPT1). | 2001 Jul-Aug |
|
Intravesical valrubicin in the treatment of carcinoma in situ of the bladder. | 2001 Jun |
|
Aroma-active components of nonfat dry milk. | 2001 Jun |
|
Births after transfer of zona-free blastocysts in oocyte donation cycles. | 2001 Mar |
|
Dehalogenation of dichloroethene in a contaminated soil: fatty acids and alcohols as electron donors and an apparent requirement for tetrachloroethene. | 2001 Mar |
|
A two-choice discrimination method to assess olfactory performance in pigtailed macaques, Macaca nemestrina. | 2001 Mar |
|
Production of poly(3-hydroxybutyrateco-3-hydroxyvalerate) from cottonseed oil and valeric acid in batch culture of Raistonia sp. strain JC-64. | 2001 May |
|
Comamonas nitrativorans sp. nov., a novel denitrifier isolated from a denitrifying reactor treating landfill leachate. | 2001 May |
|
beta-Oxidation of simvastatin in mouse liver preparations. | 2001 Oct |
|
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors. | 2001 Sep-Oct |
|
Fermentation of cottonseed and other feedstuffs in cattle rumen fluid. | 2002 Apr 10 |
|
Influence of yeast culture on ruminal microbial metabolism in continuous culture. | 2002 Aug |
|
Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine. | 2002 Aug |
|
Effects of culture conditions on the production of polyhydroxyalkanoates by Azotobacter chroococcum H23 in media containing a high concentration of alpechín (wastewater from olive oil mills) as primary carbon source. | 2002 Aug 7 |
|
A novel synthesis of (+)-biotin from L-cysteine. | 2002 Aug 9 |
|
1H and (13)C NMR spectroscopic analysis of human saliva. | 2002 Jun |
|
A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli. | 2002 Jun |
|
Modeling of growth, lactate consumption, and volatile fatty acid production by Megasphaera elsdenii cultivated in minimal and complex media. | 2002 Mar-Apr |
|
Geoglobus ahangari gen. nov., sp. nov., a novel hyperthermophilic archaeon capable of oxidizing organic acids and growing autotrophically on hydrogen with Fe(III) serving as the sole electron acceptor. | 2002 May |
|
Mass production of methane from food wastes with concomitant wastewater treatment. | 2002 Spring |
|
Psychophysical evaluation of responses to pleasant and mal-odour stimulation in human subjects; adaptation, dose response and gender differences. | 2003 Apr |
|
Effects of hydrochloric, valeric, and other volatile fatty acids on pathogenesis of ulcers in the nonglandular portion of the stomach of horses. | 2003 Apr |
|
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. | 2003 Apr |
|
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. | 2003 Jul |
|
Lack of quinine-evoked activity in rat trigeminal subnucleus caudalis. | 2003 Mar |
|
Production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with high molar fractions of 3-hydroxyvalerate by a threonine-overproducing mutant of Alcaligenes sp. SH-69. | 2003 May |
|
Heterogeneous acylation of flax fibers. Reaction kinetics and surface properties. | 2003 May-Jun |
|
Ruminal fermentation and bacterial protein synthesis of whole cottonseed coated with combinations of gelatinized corn starch and urea. | 2003 Nov |
|
Pelleted beet pulp substituted for high-moisture corn: 3. Effects on ruminal fermentation, pH, and microbial protein efficiency in lactating dairy cows. | 2003 Nov |
|
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. | 2004 Jan 27 |
|
Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction. | 2004 Jan-Feb |
|
Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. | 2004 Mar |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26663903
1.5 mM valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:24:36 GMT 2023
by
admin
on
Fri Dec 15 16:24:36 GMT 2023
|
Record UNII |
GZK92PJM7B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
||
|
JECFA EVALUATION |
VALERIC ACID
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
203-677-2
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
1370574
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
278
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
GZK92PJM7B
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
DTXSID7021655
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
7991
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
17418
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
C038780
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
1546454
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | RxNorm | ||
|
m11360
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB02406
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
GZK92PJM7B
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
100000127757
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
SUB33854
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
406833
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
VALERIC ACID
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
109-52-4
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
5390
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY | |||
|
valerate
Created by
admin on Fri Dec 15 16:24:37 GMT 2023 , Edited by admin on Fri Dec 15 16:24:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (GC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|